{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:03:05Z","timestamp":1788454985351,"version":"build-2803163510"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2020-0282_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Spinal glycinergic mechanisms inhibit the micturition reflex, and administration of glycine inhibits bladder activity in rats. Therefore, we examined whether dietary glycine would improve storage symptoms in urological outpatients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2020-0282_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 20 participants (16 men and four women) with an overactive bladder symptom score (OABSS)\u00a0\u2265\u00a03. All participants took 3\u00a0g of glucose (placebo) twice a day for the first four\u00a0weeks, then 3\u00a0g of glycine twice a day for the next four\u00a0weeks. We evaluated blood pressure, international prostate symptom score (IPSS), nocturia quality of life (N-QOL) score, OABSS, frequency of urination, sleep latency, time to first nighttime void, bladder pain, global self-assessment (GSA) evaluated urinary symptom improvement, and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2020-0282_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Glucose administered as a placebo improved urinary frequency, urine force on the IPSS, and five of the 13 items on the N-QOL. However, compared to the results before and after glucose administration, glycine treatment decreased the number of nocturnal voids, urgency, and total score for urine storage items on the IPSS. It also reduced blood pressure and improved IPSS-QOL. For the OABSS, improvements with glycine were noted in the number of nocturnal urinations, urinary urgency, urge incontinence, and total score. For the N-QOL, eight of 13 items, and the total score, improved. The actual number of nighttime urinations, sleep latency, latency to first nighttime urination, bladder pain, and GSA also improved. There were no adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2020-0282_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Glycine might improve urine storage symptoms, cardiovascular function, pain, and sleep.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2020-0282","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:43:12Z","timestamp":1617259392000},"page":"617-620","source":"Crossref","is-referenced-by-count":4,"title":["Dietary glycine improves urine storage symptoms in urology outpatients"],"prefix":"10.1515","volume":"18","author":[{"given":"Kimio","family":"Sugaya","sequence":"first","affiliation":[{"name":"Department of Urology , Kitakami Central Hospital , Kitakami , Okinawa , Japan"},{"name":"Southern Knights\u2019 Laboratory , Chatan , Okinawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Oh-Oka","sequence":"additional","affiliation":[{"name":"Kobe Medical Center , Kobe , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yamada","sequence":"additional","affiliation":[{"name":"Yamada Urological Clinic , Sagamihara , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Miyata","sequence":"additional","affiliation":[{"name":"Kitanodai Clinic , Kitahiroshima , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Ashitomi","sequence":"additional","affiliation":[{"name":"Southern Knights\u2019 Laboratory , Chatan , Okinawa , Japan"},{"name":"Department of Urology , Okinawa Hokubu Hospital , Nago , Okinawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Kadekawa","sequence":"additional","affiliation":[{"name":"Southern Knights\u2019 Laboratory , Chatan , Okinawa , Japan"},{"name":"Department of Urology , Okinawa Kyodo Hospital , Naha , Okinawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Nishijima","sequence":"additional","affiliation":[{"name":"Southern Knights\u2019 Laboratory , Chatan , Okinawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2025121209003012987_j_jcim-2020-0282_ref_001","doi-asserted-by":"crossref","unstructured":"Sugaya, K, Nishijima, S, Miyazato, M, Ogawa, Y. Central nervous control of micturition and urine storage. J Smooth Muscle Res 2005;41:117\u201332. https:\/\/doi.org\/10.1540\/jsmr.41.117.","DOI":"10.1540\/jsmr.41.117"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_002","doi-asserted-by":"crossref","unstructured":"Miyazato, M, Sugaya, K, Nishijima, S, Ashitomi, K, Morozumi, M, Ogawa, Y. Dietary glycine inhibits bladder activity in normal rats and rats with spinal cord injury. J Urol 2005;173:314\u20137https:\/\/doi.org\/10.1097\/01.ju.0000141579.91638.a3.","DOI":"10.1097\/01.ju.0000141579.91638.a3"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_003","doi-asserted-by":"crossref","unstructured":"Nishijima, S, Sugaya, K, Fukuda, T, Miyazato, M, Ashimine, S, Ogawa, Y. Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders. Int J Urol 2006;13:1479\u201383. https:\/\/doi.org\/10.1111\/j.1442-2042.2006.01653.x.","DOI":"10.1111\/j.1442-2042.2006.01653.x"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_004","doi-asserted-by":"crossref","unstructured":"Nishijima, S, Sugaya, K, Miyazato, M, Ashitomi, K, Morozumi, M, Ogawa, Y. Changes of bladder activity and glycine levels in the spinal cord and serum after spinal cord injury in rats. Biomed Res 2003;24:165\u201371. https:\/\/doi.org\/10.2220\/biomedres.24.165.","DOI":"10.2220\/biomedres.24.165"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_005","doi-asserted-by":"crossref","unstructured":"Nishijima, S, Sugaya, K, Miyazato, M, Ashitomi, K, Morozumi, M, Ogawa, Y. Relationship between bladder activity and amino acid levels in the central nervous system in rats with cerebral infarction. Biomed Res 2003;24:173\u201380. https:\/\/doi.org\/10.2220\/biomedres.24.173.","DOI":"10.2220\/biomedres.24.173"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_006","doi-asserted-by":"crossref","unstructured":"Miyazato, M, Sugaya, K, Nishijima, S, Kadekawa, K, Ashimine, S, Ogawa, Y. Intrathecal or dietary glycine inhibits bladder and urethral activity in rats with spinal cord injury. J Urol 2005;174:2397\u2013400. https:\/\/doi.org\/10.1097\/01.ju.0000180415.69705.7a.","DOI":"10.1097\/01.ju.0000180415.69705.7a"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_007","doi-asserted-by":"crossref","unstructured":"Sugaya, K, Nishijima, S, Kadekawa, K, Noguchi, K, Ueda, T, Yamamoto, H. Spinal glycinergic and GABAergic neurons inhibit the micturition reflex after electrical stimulation of the perineum in rats with pelvic venous congestion. Int J Urol 2019;26:1149\u201355. https:\/\/doi.org\/10.1111\/iju.14116.","DOI":"10.1111\/iju.14116"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_008","doi-asserted-by":"crossref","unstructured":"Yamada, S, Ito, Y, Nishijima, S, Kadekawa, K, Sugaya, K. Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder. Pharmacol Ther 2018;189:130\u201348. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.04.010.","DOI":"10.1016\/j.pharmthera.2018.04.010"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_009","doi-asserted-by":"crossref","unstructured":"Chapple, CR, Cardozo, L, Nitti, VW, Siddiqui, E, Michel, MC. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 2014;33:17\u201330. https:\/\/doi.org\/10.1002\/nau.22505.","DOI":"10.1002\/nau.22505"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_010","doi-asserted-by":"crossref","unstructured":"Barry, MJ, Fowler, FJJr, O\u2019Leary, MP, Bruskewitz, RC, Holtgrewe, HL, Mebust, WK, et al.. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement Committee of the American Urological Association. J Urol 1992;148:1549\u201357. https:\/\/doi.org\/10.1016\/s0022-5347(17)36966-5.","DOI":"10.1016\/S0022-5347(17)36966-5"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_011","doi-asserted-by":"crossref","unstructured":"Homma, Y, Yoshida, M, Seki, N, Yokoyama, O, Kakizaki, H, Gotoh, M, et al.. Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score. Urology 2006;68:318\u201323. https:\/\/doi.org\/10.1016\/j.urology.2006.02.042.","DOI":"10.1016\/j.urology.2006.02.042"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_012","doi-asserted-by":"crossref","unstructured":"Abraham, L, Hareendran, A, Mills, IW, Martin, ML, Abrams, P, Drake, MJ, et al.. Development and validation of a quality-of-life measure for men with nocturia. Urology 2004;63:481\u20136. https:\/\/doi.org\/10.1016\/j.urology.2003.10.019.","DOI":"10.1016\/j.urology.2003.10.019"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_013","doi-asserted-by":"crossref","unstructured":"Al-Khrasani, M, Mohammadzadeh, A, Balogh, M, Kir\u00e1ly, K, Barsi, S, Hajnal, B, et al.. Glycine transporter inhibitors: a new avenue for managing neuropathic pain. Brain Res Bull 2019;152:143\u201358. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.07.008.","DOI":"10.1016\/j.brainresbull.2019.07.008"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_014","doi-asserted-by":"crossref","unstructured":"Cioffi, CL. Modulation of glycine-mediated spinal neurotransmission for the treatment of chronic pain. J Med Chem 2018;61:2652\u201379. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00956.","DOI":"10.1021\/acs.jmedchem.7b00956"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_015","doi-asserted-by":"crossref","unstructured":"Yamadera, W, Inagawa, K, Chiba, S, Bannai, M, Takahashi, M, Nakayama, K. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhythm 2007;5:126\u201331. https:\/\/doi.org\/10.1111\/j.1479-8425.2007.00262.x.","DOI":"10.1111\/j.1479-8425.2007.00262.x"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_016","doi-asserted-by":"crossref","unstructured":"Hondo, M, Furutani, N, Yamasaki, M, Watanabe, M, Sakurai, T. Orexin neurons receive glycinergic innervations. PloS One 2011;6:e25076. https:\/\/doi.org\/10.1371\/journal.pone.0025076.","DOI":"10.1371\/journal.pone.0025076"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_017","doi-asserted-by":"crossref","unstructured":"Kawai, N, Sakai, N, Okuro, M, Karakawa, S, Tsuneyoshi, Y, Kawasaki, N, et al.. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology 2015;40:1405\u201316. https:\/\/doi.org\/10.1038\/npp.2014.326.","DOI":"10.1038\/npp.2014.326"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_018","doi-asserted-by":"crossref","unstructured":"Gao, H, Korim, WS, Yao, ST, Heesch, CM, Derbenev, AV. Glycinergic neurotransmission in the rostral ventrolateral medulla controls the time course of baroreflex-mediated sympathoinhibition. J Physiol 2019;597:283\u2013301. https:\/\/doi.org\/10.1113\/jp276467.","DOI":"10.1113\/JP276467"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_019","doi-asserted-by":"crossref","unstructured":"Wang, Z, Zhang, J, Chen, L, Li, J, Zhang, H, Guo, X. Glycine suppresses AGE\/RAGE signaling pathway and subsequent oxidative stress by restoring Glo1 function in the aorta of diabetic rats and in HUVECs. Oxid Med Cell Longev 2019;2019:4628962. https:\/\/doi.org\/10.1155\/2019\/4628962.","DOI":"10.1155\/2019\/4628962"},{"key":"2025121209003012987_j_jcim-2020-0282_ref_020","doi-asserted-by":"crossref","unstructured":"Rose, GE, Denys, MA, Kumps, C, Whishaw, DM, Khan, F, Everaert, KC, et al.. Nocturnal voiding frequency does not describe nocturia-related bother. Neurourol Urodyn 2019;38:1648\u201356. https:\/\/doi.org\/10.1002\/nau.24029.","DOI":"10.1002\/nau.24029"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2020-0282\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2020-0282\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:22:44Z","timestamp":1765538564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2020-0282\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,4,2]]},"published-print":{"date-parts":[[2021,9,30]]}},"alternative-id":["10.1515\/jcim-2020-0282"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2020-0282","relation":{},"ISSN":["2194-6329","1553-3840"],"issn-type":[{"value":"2194-6329","type":"print"},{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}